Discovery Life Sciences To Acquire Gentest Business From Corning Incorporated
May 2, 2022
Biospecimen Leader to Combine Gentest with Recent IVAL Acquisition to Create Leading In Vitro Drug Metabolism Services Offering
Read More
Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies
January 10, 2022
Delivery of 100,000 Samples of Capacity Annually to the Market, Empowering Genomics Researchers to Add Deep, Unbiased Proteomics Analysis to their Studies
Read More
Discovery Life Sciences Acquires In Vitro ADMET Laboratories
December 2, 2021
Biospecimen Leader Gains World’s Largest Hepatocyte Inventory And World-Renowned Scientific Leader With Latest Acquisition
Read More
Discovery Life Sciences Launches TruSight Oncology 500 (TSO500) Solid Tumor FFPE and cfDNA Services to Advance Liquid Biopsy Development and Immunotherapy Clinical Research
November 12, 2021
HUNTSVILLE, Ala., Nov. 12, 2020, Discovery Life Sciences™ (Discovery), a global leader in biospecimen solutions, genomic, cell, and immunohistochemistry (IHC) services, announces the addition of Illumina’s TruSight Oncology 500 (TSO500) technology ...
Read More
Discovery Life Sciences launches the Discovery BIOstore™
November 11, 2021
New Digital Experience Provides Customers with On-Demand Access to Millions of High Quality, Ethically Procured and Characterized Biospecimens
Read More
Discovery Life Sciences Adds Executive Leadership To Support Rapid Global Growth And Talent Acquisition
October 21, 2021
Dynamic Hr Executive To Lead Company Efforts To Hire Top Talent, Enhance Global Organizational Development Programs, And Reinforce Commitment To Workplace Diversity And Inclusion
Read More
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!
